Health
NIH ‘very concerned’ about serious side effect in coronavirus vaccine trial – FiercePharma
While the FDA weighs whether to resume its trial of AstraZeneca’s COVID-19 vaccine, which triggered a clinical hold last week after a U.K. patient was hit with a serious side effect, the NIH has launched its own study into the reaction—which could take up to…
The Food and Drug Administration (FDA) is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health (NIH) has launched an investigation of the case.
The highest levels of NIH are very concerned, said Avindra Nath, M.D., intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. Eve…
-
General22 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General18 hours agoRegional house price growth outstrips capital cities
-
General18 hours agoRestaurants on the brink as business failures plateau
-
General15 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore